Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting

European Journal of Nuclear Medicine

Volumn 29, Issue 7, 2002, Pages 855-862

  Reubi, Jean Claude ^a   Gugger, Mathias ^a   Waser, Beatrice ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Breast cancer targeting; GRP receptors; NPY receptors; Peptide receptors; Receptor co expression

Indexed keywords

BOMBESIN[4 TYROSINE] I 125; GASTRIN RELEASING PEPTIDE RECEPTOR; IODINE 125; NEUROPEPTIDE Y1 RECEPTOR; OCTREOTIDE[3 TYROSINE] I 125; PEPTIDE YY[31 LEUCINE 34 PROLINE] I 125; RECEPTOR; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; BOMBESIN RECEPTOR; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR; RADIOACTIVE IODINE; TUMOR MARKER;

ARTICLE; AUTORADIOGRAPHY; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; ISOTOPE LABELING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DENSITY; ADENOCARCINOMA; BREAST TUMOR; CLASSIFICATION; COLLOID CARCINOMA; COMPARATIVE STUDY; EVALUATION; LUNG CARCINOMA; MEDULLARY CARCINOMA; METABOLISM; METASTASIS; PAGET NIPPLE DISEASE; PATHOLOGY; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AUTORADIOGRAPHY; BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; COMPARATIVE STUDY; HUMAN; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; RECEPTORS, BOMBESIN; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, PEPTIDE; RECEPTORS, SOMATOSTATIN; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL; CARCINOMA, DUCTAL, BREAST; HUMANS;

EID: 0036095760     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0794-5     Document Type: Article

References (40)

1. Peptide receptor imaging and therapy
2. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas
3. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma
4. Indium-111-pentetreotide scintigraphy in malignant lymphomas
5. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas
6. 1-octreotide and a scintillation detector
7. Yttrium-90-labelled somatostatin-analogue for cancer treatment
8. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
9. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
10. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to EGF receptors
11. Somatostatin-receptor scintigraphy in primary breast cancer
12. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
13. Expression of somatostatin type 2A receptor correlates with estrogen receptor in human breast carcinoma
14. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies
15. Dynamic indium-111-pentetreotide scintigraphy in breast cancer
16. Breast cancer staging using technetium-99m sestamibi and indium-111-pentetreotide single-photon emission tomography
17. Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: Preliminary results
18. Somatostatin receptor in breast cancer and axillary nodes: Study with scintigraphy, histopathology and receptor autoradiography
19. In vitro identification of vasoactive intestinal peptide receptors in human tumors: Implications for tumor imaging
20. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
21. VIP breast cancer
22. GRP receptors in non-neplastic and neoplastic human breast
23. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression
24. Y1-mediated effect of neuropeptide Y in cancer: Breast carcinomas as targets
25. General considerations
26. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas
27. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide
28. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status
29. The natural history of breast carcinoma: What have we learned from screening?
30. Cochrane review on screening for breast cancer with mammography
31. Sentinel-lymph-node biopsy for breast cancer-not yet the standard of care
32. 90Y-DOTA-D-Phe1-Tyr3-octreotide
33. Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: A feasibility study
34. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies
35. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents
36. Novel analogues of neuropeptide Y with a preference for the Y1-receptor
37. Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy
38. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues
39. 105Rh labeled bombesin analogues: Enhancement of GRP receptor binding affinity utilizing aliphatic carbon chain linkers